JAGSNPHARM

Jagsonpal Pharmaceuticals Share PriceJagsonpal Pharmaceuticals

₹366.00
6.1 (1.69%)
As on 05 June, 2023 | 01:24 BSE: 507789 NSE: JAGSNPHARM

Jagsonpal Pharmaceuticals Performance

Day Range

  • Low
  • High
366.00

52 Week Range

  • Low
  • High
366.00
  • Open Price
  • Previous Close
  • Volume

Start SIP in Jagsonpal Pharmaceuticals

Start SIP

Jagsonpal Pharmaceuticals Share Price

  • Over 1 Month 7.25%
  • Over 3 Month 17.36%
  • Over 6 Month 9.04%
  • Over 1 Year 22.84%

Jagsonpal Pharmaceuticals Key Statistics

P/E Ratio 39.7
PEG Ratio 1.7
Market Cap Cr 959
Price to Book Ratio 6
EPS 11.2
Dividend 0
Relative Strength Index 63.36
Money Flow Index 80.67
MACD Signal 5.28
Average True Range 12.9

Jagsonpal Pharmaceuticals Investment Rating

  • Master Rating:
  • Jagsonpal Pharmaceuticals has an operating revenue of Rs. 236.71 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 15% is great, ROE of 16% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 200DMA and around 8% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 12% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 99 which is a GREAT score indicating consistency in earnings, a RS Rating of 62 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 112 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Jagsonpal Pharmaceuticals Financials
IndicatorMar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 5560616152
Operating Expenses Qtr Cr 5052485452
Operating Profit Qtr Cr 591361
Depreciation Qtr Cr 00001
Interest Qtr Cr 00000
Tax Qtr Cr 22300
Net Profit Qtr Cr 681000

Jagsonpal Pharmaceuticals Technicals

EMA & SMA

Current Price
₹366.00
6.1 (1.69%)
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹350.72
  • 50 Day
  • ₹341.92
  • 100 Day
  • ₹339.16
  • 200 Day
  • ₹331.21
  • 20 Day
  • ₹347.7
  • 50 Day
  • ₹335.69
  • 100 Day
  • ₹336.03
  • 200 Day
  • ₹348.44

Jagsonpal Pharmaceuticals Resistance and Support

PIVOT
₹361.27
Resistance
First Resistance ₹368.59
Second Resistance ₹377.27
Third Resistance ₹384.59
RSI 63.36
MFI 80.67
MACD Single Line 5.28
MACD 6.48
Support
First Resistance ₹352.59
Second Resistance ₹345.27
Third Resistance ₹336.59

Jagsonpal Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 40,948 2,415,523 58.99
Week 30,375 1,842,827 60.67
1 Month 31,674 1,690,741 53.38
6 Month 32,702 1,538,298 47.04

Jagsonpal Pharmaceuticals Result Highlights

Jagsonpal Pharmaceuticals Synopsis

NSE-Medical-Diversified

Jagsonpal Pharma belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 236.71 Cr. and Equity Capital is Rs. 13.10 Cr. for the Year ended 31/03/2023. Jagsonpal Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 17/08/1978 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1978PLC009181 and registration number is 009181.
Market Cap 956
Sales 237
Shares in Float 0.81
No of funds 5
Yield 1.37
Book Value 6.02
U/D Vol ratio 1
LTDebt / Equity
Alpha 0.08
Beta 0.77

Jagsonpal Pharmaceuticals

Owner NameMar-23Dec-22Sep-22Jun-22
Promoters 68.71%68.71%68.71%68.71%
Mutual Funds
Foreign Portfolio Investors 0.1%0.11%0.13%
Financial Institutions/ Banks
Individual Investors 22.23%21.12%22.77%25.26%
Others 8.96%10.06%8.39%6.03%

Jagsonpal Pharmaceuticals Management

Name Designation
Mr. R P S Kochhar Chairman Emeritus
Mr. Manish Gupta Managing Director
Mr. Harsha Raghavan Non Executive Director
Mr. Prithipal Singh Kochhar Non Executive Director
Mr. Debasis Bikash Nandy Ind. Non-Executive Director
Ms. Radhika Madhukar Dudhat Ind. Non-Executive Director
Ms. Pallavi Dinodia Gupta Ind. Non-Executive Director

Jagsonpal Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Jagsonpal Pharmaceuticals Corporate Action

Date Purpose Remarks
2023-05-23 Audited Results & Dividend
2023-02-08 Quarterly Results
2022-11-09 Quarterly Results
2022-08-09 Quarterly Results
2022-05-30 Audited & Quarterly Results
Date Purpose Remarks
2021-11-01 INTERIM Rs.4.00 per share(80%)Interim Dividend

Jagsonpal Pharmaceuticals MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Jagsonpal Pharmaceuticals FAQs

What is Share Price of Jagsonpal Pharmaceuticals ?

Jagsonpal Pharmaceuticals share price is ₹366 As on 05 June, 2023 | 01:10

What is the Market Cap of Jagsonpal Pharmaceuticals ?

The Market Cap of Jagsonpal Pharmaceuticals is ₹958.8 Cr As on 05 June, 2023 | 01:10

What is the P/E ratio of Jagsonpal Pharmaceuticals ?

The P/E ratio of Jagsonpal Pharmaceuticals is 39.7 As on 05 June, 2023 | 01:10

What is the PB ratio of Jagsonpal Pharmaceuticals ?

The PB ratio of Jagsonpal Pharmaceuticals is 6 As on 05 June, 2023 | 01:10

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number